Dynamic Diagnostics ltd

About Us

Dynamic Diagnostics Ltd is a UK-based life sciences and diagnostics company specialising in the development, manufacture, and commercialisation of in-vitro diagnostic (IVD) products and AI-enabled diagnostic technologies for microbiology, public health, food safety, and healthcare laboratories.

The company operates at the intersection of classical microbiology and modern digital innovation, delivering practical, affordable diagnostic solutions that address long-standing challenges in laboratory testing namely cost, subjectivity, limited automation, and restricted access to digital data. Dynamic Diagnostics focuses on solutions that are deployable in real-world laboratory environments, particularly small-to-medium laboratories and international markets where large, fully automated diagnostic systems are impractical or financially prohibitive.
With a strong emphasis on UK-based innovation, export growth, and scalable manufacturing, Dynamic Diagnostics is well positioned to contribute to the UK life sciences economy while delivering meaningful global health and food safety impact.

MISSION AND VISION

Mission:
To design, manufacture, and supply high-quality diagnostic solutions that improve laboratory efficiency, enhance diagnostic confidence, and deliver measurable value to customers worldwide.

Vision:
To become a recognised UK leader in practical microbiological diagnostics by combining proven assay technologies with intelligent automation, enabling laboratories to modernise incrementally and affordably.

COMMERCIAL STRATEGY
Dynamic Diagnostics operates with a commercially disciplined strategy that prioritises clear market need, modular product platforms, scalable manufacturing, regulatory readiness, and strategic partnerships. This approach ensures sustainable growth while managing technical, regulatory, and financial risk.

MARKET OPPORTUNITY
Global demand for diagnostic testing continues to grow, driven by increased focus on infectious disease surveillance, rising food and water safety standards, expanding laboratory networks in emerging markets, and stronger regulatory requirements for traceability and data integrity.
Despite this growth, many laboratories remain underserved. High-cost automated systems are often inaccessible, while manual assays suffer from subjectivity and poor data capture. Dynamic Diagnostics addresses this gap by delivering mid-market diagnostic solutions that combine established immunological assays with digital interpretation and workflow enhancement.

PRODUCTS AND TECHNOLOGY
Dynamic Diagnostics develops and manufactures latex agglutination and immunological assays for microbiological identification and screening. These products deliver rapid, reproducible results, ease of use, long shelf life, and compatibility with both manual and reader-assisted workflows.
A key growth driver is the development of compact, AI-enabled diagnostic readers that digitise traditionally manual assays. These readers reduce subjectivity, improve consistency, support barcode tracking, capture audit-ready digital records, and enable LIMS integration. The reader platforms are designed as scalable technologies capable of supporting multiple assays.

COMPETITIVE ADVANTAGE
The company’s competitive position is built on strong microbiology expertise, ownership of core reagent processes, application of AI to proven diagnostic formats, modular product design, affordability, and UK-based innovation with international export reach.

QUALITY AND REGULATORY
Dynamic Diagnostics operates under a structured quality framework aligned with ISO 13485 principles. The quality system covers design control, risk management, supplier oversight, batch traceability, and post-market surveillance, enabling efficient access to regulated markets.

MANUFACTURING AND SCALE
The company employs a scalable manufacturing model supporting small- to medium-batch production with flexible scale-up. Processes are designed to be repeatable, auditable, and transferable, supporting both direct sales and OEM partnerships.

PARTNERSHIPS
Dynamic Diagnostics collaborates with distributors, technology partners, academic groups, and public health laboratories to accelerate validation, reduce development risk, and support efficient route-to-market strategies.

ECONOMIC IMPACT AND EXPORTS
The company contributes to the UK economy through skilled job creation, domestic innovation, and export-led growth. Key international markets include Europe, Africa, the Middle East, South America, and emerging healthcare economies.

INNOVATION AND R&D
R&D activity is focused on commercially relevant innovation, including assay portfolio expansion, AI image analysis enhancement, workflow automation, and digital connectivity.

SUSTAINABILITY AND GOVERNANCE
Dynamic Diagnostics is committed to responsible growth, efficient manufacturing, ethical sourcing, and long-term partnerships. The company is led by an experienced management team with strong technical and commercial oversight.

GROWTH OUTLOOK
Over the next three to five years, the company aims to expand its diagnostic portfolio, commercialise AI-enabled readers, strengthen international distribution, increase export revenues, and continue investment in quality and regulatory capability.

CONCLUSION
Dynamic Diagnostics Ltd is a high-potential UK diagnostics company combining proven microbiology with intelligent automation to deliver practical, scalable diagnostic solutions suitable for investment, grant funding, and strategic partnership.